Product NDC: | 65841-764 |
Proprietary Name: | Ranitidine Hydrochloride |
Non Proprietary Name: | Ranitidine Hydrochloride |
Active Ingredient(s): | 25 mg/mL & nbsp; Ranitidine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-764 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091534 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130301 |
Package NDC: | 65841-764-06 |
Package Description: | 6 mL in 1 VIAL, MULTI-DOSE (65841-764-06) |
NDC Code | 65841-764-06 |
Proprietary Name | Ranitidine Hydrochloride |
Package Description | 6 mL in 1 VIAL, MULTI-DOSE (65841-764-06) |
Product NDC | 65841-764 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20130301 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |